Drug profile · INN
paromomycin sulfate
HUMATIN
paromomycin sulfate (HUMATIN) is a bacterial 70s ribosome inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — paromomycin sulfate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
paromomycin sulfate (HUMATIN) is a bacterial 70s ribosome inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial 70S ribosome inhibitor
Primary target: Bacterial 70S ribosome
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is paromomycin sulfate?
paromomycin sulfate (HUMATIN) is a bacterial 70s ribosome inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for paromomycin sulfate?
HUMATIN is a marketed brand name for paromomycin sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of paromomycin sulfate?
paromomycin sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.